The Truth About Wegovy: Convenience Isn’t Enough –

The Truth About Wegovy: Convenience Isn’t Enough –

An oral formulation of Wegovy may facilitate initiation of treatment for some patients, particularly those who dislike injections. However, the primary reason most patients stop GLP-1 therapy is not the delivery method — it’s the side effects. Nausea, GI issues, and overall tolerability remain the most significant barriers to long-term adherence. A pill may improve…

Read More
Zero-Tolerance to Falsified Medicines: How MVS Pharma GmbH Ensures Full EU GDP Compliance

Zero-Tolerance to Falsified Medicines: How MVS Pharma GmbH Ensures Full EU GDP Compliance

December 27, 2025 Table of Contents EU GDP Expectations for Prevention of Falsified Medicines MVS Pharma’s Risk-Based Approach to Falsified Medicines Prevention Controlled Handling of Suspected Falsified Medicines Continuous Awareness and Preventive Controls Conclusion The prevention of falsified medicines is a critical responsibility under the EU Good Distribution Practice (GDP) Guidelines. Falsified medicinal products pose…

Read More
Missteps in GMP Facilities and Equipment Maintenance

Missteps in GMP Facilities and Equipment Maintenance

Construction and maintenance of manufacturing buildings and equipment fall under good manufacturing practices (GMPs) regulations (1–5). Pharmaceutical manufacturers can comply with these rules in the form of risk-based maintenance programs. Pharmaceutical Technology® spoke with David Basile, VP Technical Operations, Americas, Hovione, about how companies can meet these requirements for GMP facilities and equipment and some…

Read More
‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

New Delhi: A pharma group has sought extension for those production units that have already submitted upgradation plans and can demonstrate execution progress, even as the drug regulatory authority seems reluctant to extend the December 31 deadline for implementing the revised schedule aimed at strengthening good manufacturing practices. The Indian Drug Manufacturers’ Association (IDMA) has…

Read More
The Impact of Private Equity on Healthcare Quality –

The Impact of Private Equity on Healthcare Quality –

When private equity firms take over hospitals and elder care facilities, the core mission of care often gets replaced by a mission of financial extraction. Cost-cutting becomes the primary lever for profit, leading to understaffing, worker burnout, reduced quality of care, and the erosion of patient dignity — especially among vulnerable elderly populations. Healthcare workers…

Read More
PharmTech’s Top 10 Articles of 2025

PharmTech’s Top 10 Articles of 2025

Our top 10 articles for the year track seismic shifts across the pharmaceutical landscape, from high-level trade policy and drug pricing to fundamental regulatory stability and quality control. They highlight policy upheaval, regulatory complexity and quality control, and market disruption in both economics and therapy development. The industry faced intense pressure this year to adjust…

Read More
Embracing Patient Needs for Success –

Embracing Patient Needs for Success –

The pharma industry faces a profound trust crisis, but a forward-thinking minority within the sector recognizes that the solution lies not in defensive marketing, but in genuine patient-centricity. These innovators understand a counterintuitive truth: by placing patient needs genuinely first—through transparent pricing, accessible medications, and meaningful engagement—pharmaceutical companies can rebuild trust and unlock sustainable profitability….

Read More

Bruno Vision Care Reports the US FDA Clearance of Deseyne for Presbyopia

Shots: FDA has cleared Deseyne, a daily disposable soft contact lens for presbyopia that uses patented Extended Depth of Focus technology Deseyne provides continuous near, intermediate, & distance vision through Cataltheia’s patented hyper-refractive central zone, showing a clinical advantage over multifocal lenses with minimal patient adaptation, strong comfort, & no adverse events reported in studies Made…

Read More